hDHODH-IN-10 is a potent, selective, and orally active inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an IC50 value of 10.9 nM; it inhibits cancer cell proliferation and can be used in cancer research, such as for acute myeloid leukemia (AML) and colon cancer.